Vascular Solutions: Injunction against Boston Scientific's Guidezilla vacated Vascular Solutions (VASC) announced that a three judge panel of the U.S. Court of Appeals for the Federal Circuit vacated the preliminary injunction that was previously issued by the District Court for the District of Minnesota effective January 13 against Boston Scientific's (BMY) Guidezilla guide extension catheter. In its one paragraph opinion vacating the injunction, the court noted that a preliminary injunction is a "drastic and extraordinary remedy that is not to be routinely granted" and "at this stage of the case the record is too incomplete . . . to warrant the grant of a preliminary injunction." The court's ruling on the preliminary injunction does not affect the underlying patent litigation, which is currently scheduled to be ready for trial on or after March 2015 in the District Court for the District of Minnesota.